PROTACs in the Management of Prostate Cancer

Cancer treatments with targeted therapy have gained immense interest due to their low levels of toxicity and high selectivity. Proteolysis-Targeting Chimeras (PROTACs) have drawn special attention in the development of cancer therapeutics owing to their unique mechanism of action, their ability to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yedla, Poornachandra, Babalghith, Ahmed O., Andra, Vindhya Vasini, Syed, Riyaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179857/
https://www.ncbi.nlm.nih.gov/pubmed/37175108
http://dx.doi.org/10.3390/molecules28093698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179857/
https://www.ncbi.nlm.nih.gov/pubmed/37175108
http://dx.doi.org/10.3390/molecules28093698

Ejemplares similares